Benefit of Rituximab Addition to High-Dose Programs with Autograft for B-Cell Lymphoma: A Multicenter GITIL Survey on 957 Patients.Corrado Tarella, Alessandro Rambaldi, Salvatore Mirto et al.|Blood|2006Cited by 4
P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patientsManuela Zanni, Corrado Tarella, Paolo Corradini et al.|Leukemia Research|2007Cited by 1
Incidence of Secondary Myelodysplastic Syndrome/Acute Leukemia in 1,266 Lymphoma Patients Following High-Dose Therapy and Autograft: A Study from GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).Manuela Zanni, Corrado Tarella, Salvatore Mirto et al.|Blood|2006Cited by 1